Clinical Trial Update: Nebulized Bacteriophage Therapy in Cystic Fibrosis Patients With Chronic Pseudomonas Aeruginosa Pulmonary Infection [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating nebulized bacteriophage therapy for chronic Pseudomonas aeruginosa lung infection in cystic fibrosis patients has complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis
• Pseudomonas Aeruginosa Infection

Drugs mentioned

• Nebulized bacteriophage therapy (bacteriophage therapy)

Snippet

Sponsor: BiomX, Inc. | Conditions: Chronic Pseudomonas Aeruginosa Infection, Cystic Fibrosis | Phase 1, Phase 2 | Status: COMPLETED